Skip to content
Menu

UBS Maintains Buy on Dentsply Sirona, Lowers Price Target to $13

Benzinga Newsdesk 22 hours ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

UBS analyst Kevin Caliendo maintains Dentsply Sirona (NASDAQ:XRAY) with a Buy and lowers the price target from $17 to $13.

UBS analyst Kevin Caliendo maintains Dentsply Sirona (NASDAQ:XRAY) with a Buy and lowers the price target from $17 to $13.

Read at benzinga.com